Towards

ultra-precision medicine

Vision

Early identification of therapeutic targets to improve outcome of cancer patients.

Three pillars

The principle of this program is to assess cancer in its complexity by generating multi-dimensional, multi-scale molecular portraits of cancer in order to predict outcome and drug sensitivity.

Latest from the blog

PRISM: a new Institut Hospitalo Universitaire for Gustave Roussy

Gustave Roussy's Prism program, labeled "National precision center against cancer" by the National Research Agency (ANR) in 2018, obtained the "Institut Hospitalo-Universitaire" (IHU) label. Based on a transformative vision of cancer care, Prism is supported by a...

Thomas gilbert was at Gustave Roussy

Thomas Gilbert was at Gustave Roussy to conclude his very remarquable charity adventure "Vent dans le dos contre la maladie" (Wind in the back against illness). The adventurer had set himself the goal of cycling accross Canada, alone, from Vancouver to Quebec (5500...

Prism center is a one-of-a-kind partnership between

© 2022 National Precision Medicine Center in Oncology